Bayer Alerts Investors Yaz Settlements Will Continue

Share Article

The Web’s largest source for information on Yaz research, side effects and legal news is available at The Yaz Resource Center. Visit http://www.YazLawsuit.com

YAZ LAWSUIT
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

In its latest financial report to shareholders, German drug maker Bayer indicated it had reserved an additional $262.5 million to settle claims by patients over Yaz and Yasmin blood clots, according to Dow Jones staff writer Friedrich Geiger on October 30, 2012 in an article for 4-traders.com.

The news follows a report from the American College of Obstetricians and Gynecologists in October warning that birth control pills containing drospirenone like Yaz and Yasmin may have a higher risk of causing blood clots, according to the Chicago Tribune on October 24, 2012.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may have be attributed to Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

Bloomberg News had reported on July 31st that Bayer would reserve $610 million to settle more Yaz cases at that time, for an average of nearly $212,000 per case. The report also stated Yaz settlements would be limited to cases involving blood clot injuries.

In October of 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found that drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

A federal Multi-District Litigation court was established in Illinois to handle Yaz lawsuits filed by those injured. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.

The news of additional Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website